Literature DB >> 28426491

Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy.

Robert T Jensen1, Jeffrey A Norton.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28426491      PMCID： PMC5407310          DOI： 10.1097/MPA.0000000000000825

Source DB:  PubMed          Journal:  Pancreas        ISSN： 0885-3177            Impact factor:   3.327


× No keyword cloud information.
  82 in total

1.  Long-term follow-up of patients with multiple endocrine neoplasia type 1.

Authors:  Akihiro Sakurai; Miyuki Katai; Koh Yamashita; Jun-Ichiro Mori; Yoshimitsu Fukushima; Kiyoshi Hashizume
Journal:  Endocr J       Date:  2007-03-20       Impact factor: 2.349

2.  Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome.

Authors:  J A Norton; H R Alexander; D L Fraker; D J Venzon; F Gibril; R T Jensen
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

3.  MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines.

Authors:  P Goudet; A Dalac; M Le Bras; C Cardot-Bauters; P Niccoli; N Lévy-Bohbot; H du Boullay; X Bertagna; P Ruszniewski; F Borson-Chazot; B Vergès; J L Sadoul; F Ménégaux; A Tabarin; J M Kühn; P d'Anella; O Chabre; S Christin-Maitre; G Cadiot; C Binquet; B Delemer
Journal:  J Clin Endocrinol Metab       Date:  2015-01-16       Impact factor: 5.958

4.  Results of (68)Gallium-DOTATATE PET/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1.

Authors:  Samira M Sadowski; Corina Millo; Candice Cottle-Delisle; Roxanne Merkel; Lily A Yang; Peter Herscovitch; Karel Pacak; William F Simonds; Stephen J Marx; Electron Kebebew
Journal:  J Am Coll Surg       Date:  2015-04-20       Impact factor: 6.113

5.  Selective venous sampling for gastrin to localize gastrinomas. A prospective assessment.

Authors:  J A Cherner; J L Doppman; J A Norton; D L Miller; A G Krudy; J P Raufman; M J Collen; P N Maton; J D Gardner; R T Jensen
Journal:  Ann Intern Med       Date:  1986-12       Impact factor: 25.391

6.  Cause of death in multiple endocrine neoplasia type 1.

Authors:  S Wilkinson; B T Teh; K R Davey; J P McArdle; M Young; J J Shepherd
Journal:  Arch Surg       Date:  1993-06

7.  Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study.

Authors:  J A Norton; M J Cornelius; J L Doppman; P N Maton; J D Gardner; R T Jensen
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

8.  Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).

Authors:  Secondo Lastoria; Francesca Marciello; Antongiulio Faggiano; Luigi Aloj; Corradina Caracò; Michela Aurilio; Laura D'Ambrosio; Francesca Di Gennaro; Valeria Ramundo; Luigi Camera; Leonardo De Luca; Rosa Fonti; Vincenzo Napolitano; Annamaria Colao
Journal:  Endocrine       Date:  2015-08-05       Impact factor: 3.633

9.  Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies.

Authors:  Tetsuhide Ito; Robert T Jensen
Journal:  Int J Endocr Oncol       Date:  2016-01-18

10.  Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.

Authors:  Luisa Circelli; Valeria Ramundo; Vincenzo Marotta; Concetta Sciammarella; Francesca Marciello; Michela Del Prete; Lina Sabatino; Daniela Pasquali; Francesco Izzo; Stefania Scala; Annamaria Colao; Antongiulio Faggiano; Vittorio Colantuoni
Journal:  J Cell Mol Med       Date:  2015-03-30       Impact factor: 5.310
View more
  10 in total

1.  Low risk for all-cause mortality among patients with lung neuroendocrine tumors co-diagnosed with pituitary adenomas.

Authors:  Naama Peltz-Sinvani; Ruth Percik; Inbal Uri; Sapir Kon Kfir; Amir Tirosh; Amit Tirosh
Journal:  Endocrine       Date:  2021-05-12       Impact factor: 3.633

Review 2.  Gastrinomas: Medical or Surgical Treatment.

Authors:  Jeffrey A Norton; Deshka S Foster; Tetsuhide Ito; Robert T Jensen
Journal:  Endocrinol Metab Clin North Am       Date:  2018-09       Impact factor: 4.741

3.  Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing.

Authors:  David C Metz; Guillaume Cadiot; Pierre Poitras; Tetsuhide Ito; Robert T Jensen
Journal:  Int J Endocr Oncol       Date:  2017-10-11

Review 4.  Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies.

Authors:  Lingaku Lee; Tetsuhide Ito; Robert T Jensen
Journal:  Expert Rev Anticancer Ther       Date:  2018-07-17       Impact factor: 4.512

Review 5.  Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies.

Authors:  Lingaku Lee; Tetsuhide Ito; Robert T Jensen
Journal:  Expert Rev Anticancer Ther       Date:  2019-11-27       Impact factor: 4.512

6.  A Preoperative Clinical Risk Score Including C-Reactive Protein Predicts Histological Tumor Characteristics and Patient Survival after Surgery for Sporadic Non-Functional Pancreatic Neuroendocrine Neoplasms: An International Multicenter Cohort Study.

Authors:  Florian Primavesi; Valentina Andreasi; Frederik J H Hoogwater; Stefano Partelli; Dominik Wiese; Charlotte Heidsma; Benno Cardini; Eckhard Klieser; Katharina Marsoner; Uwe Fröschl; Sabine Thalhammer; Ines Fischer; Georg Göbel; Andreas Hauer; Tobias Kiesslich; Philipp Ellmerer; Reinhold Klug; Daniel Neureiter; Helwig Wundsam; Franz Sellner; Peter Kornprat; Reinhold Függer; Dietmar Öfner; Elisabeth J M Nieveen van Dijkum; Detlef K Bartsch; Ruben H J de Kleine; Massimo Falconi; Stefan Stättner
Journal:  Cancers (Basel)       Date:  2020-05-14       Impact factor: 6.639

Review 7.  Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations.

Authors:  Gabriel Benyomo Mpilla; Philip Agop Philip; Bassel El-Rayes; Asfar Sohail Azmi
Journal:  World J Gastroenterol       Date:  2020-07-28       Impact factor: 5.742

Review 8.  Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies.

Authors:  Lingaku Lee; Irene Ramos-Alvarez; Robert T Jensen
Journal:  Cancers (Basel)       Date:  2022-02-28       Impact factor: 6.639

9.  A Direct Comparison of Patients With Hereditary and Sporadic Pancreatic Neuroendocrine Tumors: Evaluation of Clinical Course, Prognostic Factors and Genotype-Phenotype Correlations.

Authors:  Przemysław Soczomski; Beata Jurecka-Lubieniecka; Aleksandra Krzywon; Alexander Jorge Cortez; Stanisław Zgliczynski; Natalia Rogozik; Małgorzata Oczko-Wojciechowska; Agnieszka Pawlaczek; Tomasz Bednarczuk; Barbara Jarzab
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-28       Impact factor: 5.555

Review 10.  Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.

Authors:  Lingaku Lee; Irene Ramos-Alvarez; Tetsuhide Ito; Robert T Jensen
Journal:  Int J Mol Sci       Date:  2019-10-16       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.